Featured Research

from universities, journals, and other organizations

Silenced Gene Suggests Greater Risk, Possible Marker For African-Americans With Prostate Cancer

Date:
June 20, 2005
Source:
University of California - San Francisco
Summary:
Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC).

Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC).

"This could be one of the mechanisms for the higher incidence of prostate cancer in African-Americans compared to Caucasians," said Rajvir Dahiya, PhD, Director of the Urology Research Center at SFVAMC and the principle investigator of the study. "When tumor suppression activity goes down, the tumor progresses much faster."

In the United States, African-Americans have almost 1.7 times the incidence and mortality of prostate cancer compared to Caucasians (272 per 100,000 vs. 164 per 100,000, respectively).

Researchers found that the GSTP1 gene is temporarily inactivated, or "silenced," through the process of hypermethylation, in which methyl groups (CH3) replace hydrogen atoms (H) in cytosine, one of the four protein bases of the gene's DNA.

The study is the first to investigate and discover ethnic differences in GSTP1 hypermethylation between African-Americans, Caucasians, and Asians. It is being published in the August 20, 2005 issue of the International Journal of Cancer, currently available online.

The researchers noted that "in the African-American population, GSTP1 methylation is a particularly good biomarker" for prostate cancer, since it is more likely to indicate the presence of the disease than in other ethnic groups. Thus, for African-Americans, it is both a potential cause of disease and a tool for diagnosing it, according to Dahiya, who is also a professor of urology at the University of California, San Francisco (UCSF).

Although the researchers gathered their data using pathology samples, GSTP1 can be measured in body fluids. Dahiya says that for African-Americans with high levels of GSTP1 hypermethylation, appropriate treatment strategies would include more aggressive treatment and frequent monitoring.

In the current study, Dahiya and his fellow researchers studied pathology samples from 291 prostate cancer patients (170 Asian, 44 African-American, and 77 Caucasian-American), and compared them with 172 samples (96 Asian, 38 African-American, and 38 Caucasian-American) from patients with benign prostate hypertrophy, or enlarged prostate. All Asian samples were obtained from Shimane University Hospital in Izumo, Japan; all Caucasian and African-American samples were obtained at SFVAMC. From each sample, the researchers took DNA, amplified it using polymerase chain reaction techniques, and looked for reactions indicating the presence of methylation. Through direct DNA sequencing, they then discovered which regions of GSTP1 were methylated.

The study does not explore possible causes for GSTP1 hypermethylation. However, Dahiya noted that the incidence of prostate cancer among Africans in Africa is significantly lower than among African-Americans, and that Asians in Asia have lower rates than Asian-Americans. "That tells us that dietary and environmental factors play a very important role in this disease," he said.

Dahiya emphasized that the change observed in GSTP1 is epigenetic -- a potentially reversible change in gene function -- as opposed to a mutation, which is an irreversible change in a gene's DNA sequencing. In other studies, Dahiya has in fact reactivated GSTP1 by reversing hypermethylation. However, the compound that does this is highly toxic, and researchers are exploring other avenues to accomplish the same result. Soybean products and other foods containing plant estrogens seem particularly promising, noted Dahiya. "In prostate cancers that turn out to be linked to diet, we cannot repair genetic damage," he said. "But hopefully we can repair epigenetic damage through diet management."

Dahiya is currently conducting a nationwide study of prostate cancer and hypermethylation rates among much larger samples of Caucasians, Asian-Americans, and African-Americans, "to make this study more valid and stronger."

Co-investigators include Hideki Enokida, MD, PhD, of SFVAMC, UCSF, and Kagoshima University, Japan; Hiroaki Shiina, MD, PhD, and Shinji Urakami, MD, of SFVAMC, UCSF, and Shimane University, Japan; Mikio Igawa, MD, of Shimane University, Japan; Tatsuya Ogishima, MD, Deepa Pookot, MS, Long-Cheng Li, and Z. Laura Tabatabai, MD, of SFVAMC and UCSF; Motoshi Kawahara, MD, and Masayuki Nakagawa, MD, PhD, of Kagoshima University, Japan; and Christopher J. Kane, MD, and Peter R. Carroll, MD, of SFVAMC and UCSF.

###

The study was funded by a grant from the National Institutes of Health that was administered by the Northern California Institute for Research and Education (NCIRE), and grants from the U.S. Department of Veterans Affairs.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Francisco. "Silenced Gene Suggests Greater Risk, Possible Marker For African-Americans With Prostate Cancer." ScienceDaily. ScienceDaily, 20 June 2005. <www.sciencedaily.com/releases/2005/06/050620003354.htm>.
University of California - San Francisco. (2005, June 20). Silenced Gene Suggests Greater Risk, Possible Marker For African-Americans With Prostate Cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/06/050620003354.htm
University of California - San Francisco. "Silenced Gene Suggests Greater Risk, Possible Marker For African-Americans With Prostate Cancer." ScienceDaily. www.sciencedaily.com/releases/2005/06/050620003354.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins